You will respect my authority (warning: South Park clip). In one of the stranger moves of 2017, the American Diabetes Association tried really really, hard (think someone looking over your shoulder) to lockdown photo sharing via social media at their annual conference. Twits were greeted with “Thanks for joining us at #2017ADA! Photography isn’t allowed during presentations — we’d appreciate it if you’d delete this tweet.” Charming. And it gets better. The rebukes even came when people shared photos during an open innovation session. @MatthewJDalby said it best, “The first rule of open innovation: You don’t talk about open innovation.” We are a little jealous we didn’t come up with that one. We think the burden of privacy in today’s world sits with the presenter, not the audience. Agreed?
UnitedHealthcare has announced that Medtronic will soon become the sole in-network insulin pump manufacturer for UHC’s commercial and Medicaid plan members. Though patients are permitted to continue using their existing pump until it is out of warranty and needs to be replaced, patients are not exactly jazzed about this new lack of options. Patients, advocacy groups, and not surprisingly, Medtronic’s competitor Tandem Diabetes Care, are pushing back publically. Patients and advocacy groups are using Twitter hashtags #DiabetesAccessMatters and #MyPumpMyChoice to voice their displeasure. One tweet reads, “If you can’t decide what to have for lunch just ask @MDT_Diabetes & @myUHC they know everything #MypumpMyChoice.” Whether sarcasm and tweets will be enough to change UHC’s policy remains to be seen.